Influenza antiviral expenditures and outpatient prescriptions in the United States, 2003-2012

Pharmacotherapy

Volumn 35, Issue 11, 2015, Pages 991-997

  Suda, Katie J ^a   Hunkler, Robert J ^b   Matusiak, Linda M ^b   Schumock, Glen T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b IQVIA   (United States)

Author keywords

adamantanes; influenza; neuraminidase inhibitors; prescribing practices

Indexed keywords

OSELTAMIVIR; RIMANTADINE; ZANAMIVIR; ANTIVIRUS AGENT;

CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FLU LIKE SYNDROME; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; OUTPATIENT CARE; PANDEMIC; PHARMACY; PRESCRIPTION; PRISON; RETROSPECTIVE STUDY; REVIEW; UNITED STATES; UNIVERSITY; VETERINARY CLINIC; DRUG COST; DRUG UTILIZATION; ECONOMICS; FACTUAL DATABASE; INFLUENZA, HUMAN; OUTPATIENT; STATISTICS AND NUMERICAL DATA;

ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG COSTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HUMANS; INFLUENZA, HUMAN; OUTPATIENTS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84948133064     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1656     Document Type: Review

References (27)

1. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep 2010; 59: 1057-62.
2. Thompson WW, Shay DK, Weintraub E, et al., Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333-40.
3. Jefferson T, Doshi P,. Multisystem failure: the story of anti-influenza drugs. BMJ 2014; 348: g2263.
4. Genentech USA, Inc. Tamiflu [package insert]. South San Francisco, CA; 2011.
5. GlaxoSmithKlline. Relenza [package insert]. Research Triangle Park, NC; 2013.
6. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM,; Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60: 1-24.
7. Hsu J, Santesso N, Mustafa R, et al., Antivirals for influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2013; 7 (Suppl 2): 76-81.
8. Muthuri SG, Venkatesan S, Myles PR, et al., Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014; 2: 305-404.
9. Jefferson T, Jones MA, Doshi P, et al., Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 2014; 4: CD008965.
10. Centers for Disease Control and Prevention. Have you heard: CDC recommendations for influenza antiviral medications remain unchanged, April 2014. Available from http://www.cdc.gov/media/haveyouheard/stories/Influenza-antiviral2.html. Accessed June 6, 2015.
11. Abbasi K,. The missing data that cost $20bn. BMJ 2014; 348: g2695.
12. Bureau of Labor Statistics. Consumer Price Index calculator. Available from http://www.bls.gov/data/inflation-calculator.htm. Accessed June 6, 2015.
13. Adriaenssens N, Coenen S, Kroes AC, et al., European surveillance of antimicrobial consumption (ESAC): systemic antiviral use in Europe. J Antimicrob Chemother 2011; 66: 1897-905.
14. Centers for Disease Control and Prevention. A weekly influenza surveillance report prepared by the Influenza Division, June 2015. Available from http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html. Accessed June 6, 2015.
15. Centers for Disease Control and Prevention. Overview of influenza surveillance in the United States, January 2015. Available from http://www.cdc.gov/flu/weekly/overview.htm. Accessed June 6, 2015.
16. Doloresco F, Fominaya C, Schumock GT, et al., Projecting future drug expenditures: 2011. Am J Health Syst Pharm 2011; 58: 931-2.
17. Schumock GT, Li EC, Suda KJ, et al., National trends in prescription drug expenditures and projections for 2014. Am J Health Syst Pharm 2014; 71: 482-99.
18. Centers for Disease Control and Prevention. 2006-2007 influenza (flu) season, July 2009. Available from http://www.cdc.gov/flu/pastseasons/0607season.htm. Accessed June 6, 2015.
19. Centers for Disease Control and Prevention. 2007-2008 influenza (flu) season, June 2008. Available from http://www.cdc.gov/flu/pastseasons/0708season.htm. Accessed June 6, 2015.
20. Centers for Disease Control and Prevention. Updated interim influenza vaccination recommendations-2004-2005 influenza season. MMWR Morb Mortal Wkly Rep 2004; 53: 1183-4.
21. American Society of Health-System Pharmacists. Oseltamivir phosphate oral suspension, May 2009. Available at: http://www.ashp.org/DrugShortages/ResolvedShortages/Bulletin.aspx?id=71. Accessed May 31, 2015.
22. Atkins CY, Patel A, Taylor TH Jr, et al., Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerg Infect Dis 2011; 17: 1591-8.
23. Dharan NJ, Beekmann SE, Fiore A, et al., Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses. Antiviral Res 2010; 88: 182-6.
24. Centers for Disease Control and Prevention. Overview of Influenza Surveillance in the United States, October 2011. Available from http://www.cdc.gov/flu/weekly/overview.htm. Accessed June 6, 2015.
25. Copeland KR, Allen AE,. Basic models for mapping prescription drug data. Proceedings of the survey research methods section, American Statistical Association 2005, The American Statistical Association. Alexandria, VA, 2005; 2904-9.
26. Hogan WR, Tsui FC, Ivanov O, et al., Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products. J Am Med Inform Assoc 2003; 10: 555-62.
27. Liu TY, Sanders JL, Tsui FC, Espino JU, Dato VM, Suyama J,. Association of over-the-counter pharmaceutical sales with influenza-like-illnesses to patient volume in an urgent care setting. PLoS One 2013; 8: e59273.